Intellia Thera CS (NTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NTLA | RXRX | INBX | ||
| Company | Intellia Thera CS | Recursion Pharmaceuticals Inc Cl A | Inhibrx Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.26 | 3.52 | 124.27 | ||
| High | 13.45 | 3.54 | 127.34 | ||
| Low | 13.00 | 3.42 | 122.36 | ||
| Last | 13.11 | 3.44 | 123.93 | ||
| Change | -0.08 | -0.05 | -1.41 | ||
| Percent Change | -0.61% | -1.43% | -1.12% | ||
| Volume | 2,433,384 | 10,872,354 | 310,834 | ||
| 20-Day Average Volume | 3,439,329 | 15,652,237 | 264,837 | ||
| Previous | 13.19 | 3.49 | 125.34 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 12.07 | 3.29 | 97.18 | ||
| 20-Day Raw Stochastic | 81.38% | 73.25% | 86.02% | ||
| 20-Day Relative Strength | 53.03 | 53.27 | 69.63 | ||
| Weighted Alpha | +36.03 | -24.78 | +123.26 | ||
| Today's Opinion | 24% Sell | 24% Sell | 72% Buy | ||
| Yesterday's Opinion | 24% Sell | 24% Sell | 72% Buy | ||
| Last Month's Opinion | 24% Sell | 88% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.39% since 08/20/26 | +2.99% since 08/20/26 | +24.99% since 08/20/26 | ||
| Low | 12.24 on 08/24/26 | 3.21 on 08/24/26 | 94.20 on 08/24/26 | ||
| High | 13.73 on 08/25/26 | 3.63 on 08/21/26 | 131.01 on 08/26/26 | ||
| 1-Month | |||||
| %Chg | +22.87% since 07/27/26 | +14.29% since 07/27/26 | +50.31% since 07/27/26 | ||
| Low | 10.15 on 07/28/26 | 2.86 on 07/28/26 | 77.50 on 07/29/26 | ||
| High | 13.73 on 08/25/26 | 3.63 on 08/21/26 | 131.01 on 08/26/26 | ||
| 3-Month | |||||
| %Chg | -2.46% since 05/27/26 | +8.52% since 05/27/26 | +20.32% since 05/27/26 | ||
| Low | 10.15 on 07/28/26 | 2.84 on 07/20/26 | 77.50 on 07/29/26 | ||
| High | 18.48 on 07/02/26 | 4.09 on 07/06/26 | 131.01 on 08/26/26 | ||
| 6-Month | |||||
| %Chg | -4.86% since 02/27/26 | -6.27% since 02/27/26 | +67.18% since 02/27/26 | ||
| Low | 10.15 on 07/28/26 | 2.77 on 05/19/26 | 57.30 on 03/27/26 | ||
| High | 18.48 on 07/02/26 | 4.09 on 07/06/26 | 155.29 on 04/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,848,275 | 1,868,344 | 1,844,754 | ||
| Shares Outstanding, K | 140,127 | 535,342 | 14,718 | ||
| Annual Sales, $M | 67,670,000 | 74,680,000 | 1,300,000 | ||
| Annual Net Income, $M | -412,690,000 | -644,760,000 | -140,060,000 | ||
| Last Qtr Sales, $M | 7,660,000 | 7,670,000 | 0 | ||
| Last Qtr Income, $M | -106,630,000 | -131,010,000 | -36,650,000 | ||
| 60-Month Beta | 1.81 | 1.03 | 3.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.80 on 08/06/26 | -0.25 on 08/05/26 | -2.34 on 08/13/26 | ||
| Latest Earnings Date | 11/05/26 | 11/04/26 | 11/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||